USANA Health Sciences, Inc.
USNA
$19.41
-$0.50-2.51%
NYSE
| 04/04/2026 | 01/03/2026 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.87M | 10.76M | 16.99M | 34.12M | 34.90M |
| Total Depreciation and Amortization | 39.25M | 39.70M | 35.30M | 31.29M | 27.39M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.95M | 14.97M | 9.64M | 8.49M | 7.52M |
| Change in Net Operating Assets | -47.44M | -43.08M | -30.41M | -10.88M | -11.01M |
| Cash from Operations | 16.63M | 22.35M | 31.52M | 63.02M | 58.79M |
| Capital Expenditure | -13.67M | -13.82M | -12.83M | -12.03M | -9.68M |
| Sale of Property, Plant, and Equipment | 3.95M | 3.91M | 0.00 | 61.00K | 61.00K |
| Cash Acquisitions | -- | -- | -203.34M | -203.34M | -203.34M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 865.00K | -207.00K | -207.00K | -207.00K | 53.00K |
| Cash from Investing | -8.85M | -10.13M | -216.37M | -215.51M | -212.90M |
| Total Debt Issued | 21.60M | 17.60M | 24.60M | 24.60M | 23.15M |
| Total Debt Repaid | -30.60M | -26.60M | -24.59M | -24.59M | -1.47M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -17.65M | -29.85M | -29.87M | -29.85M | -14.65M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.13M | -1.75M | -1.26M | -379.00K | -- |
| Cash from Financing | -29.78M | -40.60M | -31.13M | -30.23M | 7.03M |
| Foreign Exchange rate Adjustments | 5.29M | 5.11M | -3.61M | 1.67M | -1.67M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.71M | -23.27M | -219.59M | -181.05M | -148.74M |